These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 6243728
1. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma. Nelson RL, Service FJ, Go VL. Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728 [Abstract] [Full Text] [Related]
2. Glucose-induced GIP levels in patients with insulinoma. Tamburrano G, Lala A, Mauceri M, Leonetti F, Andreani D. Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816 [Abstract] [Full Text] [Related]
4. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin. Rizza RA, Haymond MW, Verdonk CA, Mandarino LJ, Miles JM, Service FJ, Gerich JE. Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168 [Abstract] [Full Text] [Related]
5. Plasma glucagon in insulinoma. Ohneda A, Matsuda K, Horigome K, Ishii S, Yanbe A, Maruhama Y. Acta Diabetol Lat; 1977 May; 14(5-6):219-28. PubMed ID: 207064 [Abstract] [Full Text] [Related]
6. Radioimmunoassay in diagnosis, localization and treatment of endocrine tumours in gut and pancreas. Rehfeld JF. Scand J Gastroenterol Suppl; 1979 May; 53():33-8. PubMed ID: 225784 [Abstract] [Full Text] [Related]
7. Gastric inhibitory polypeptide, insulin, and glucose changes produced by growth hormone, prednisolone, glucagon, insulin, fasting, or diazoxide. Williams RH. Proc Soc Exp Biol Med; 1979 Oct; 162(1):157-62. PubMed ID: 504226 [No Abstract] [Full Text] [Related]
8. Effects of somatostatin on insulin and glucagon in patients with insulinoma. Fallucca F, Mirabella C, Tamburrano G, Gambardella S, Aufieri G, Barbetti F, Andreani D. J Endocrinol Invest; 1979 Oct; 2(3):257-60. PubMed ID: 231062 [Abstract] [Full Text] [Related]
11. Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics. Krarup T, Madsbad S, Tronier B. Diabete Metab; 1984 Sep; 10(3):171-4. PubMed ID: 6386555 [Abstract] [Full Text] [Related]
15. Direct effect of insulin on secretion of insulin, glucagon, gastric inhibitory polypeptide, and gastrin during maintenance of normoglycemia. Service FJ, Nelson RL, Rubenstein AH, Go VL. J Clin Endocrinol Metab; 1978 Sep; 47(3):488-93. PubMed ID: 400722 [Abstract] [Full Text] [Related]
16. Study of hypoglycemic patients by the glucose clamp technique using the artificial pancreas. Pontiroli AE, Secchi A, Dabandi M, Alberetto M, Bosi E, Fantaguzzi S, Pozza G. J Clin Endocrinol Metab; 1983 Dec; 57(6):1297-300. PubMed ID: 6313737 [Abstract] [Full Text] [Related]
17. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels. McDonald TJ, Dupre J, Caussignac Y, Radziuk J, Van Vliet S. Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682 [Abstract] [Full Text] [Related]
19. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma. Pun KK, Young RT, Wang C, Tam CF, Ho PW. J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361 [Abstract] [Full Text] [Related]